This inventor holds 1 USPTO granted patent. Top assignee: Zakrytoe Aktsionernoe Obschestvo “Russkie Biotechnologll”. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Evgeniy Sergeevich Severin: Innovator in Cancer Treatment
Introduction
Evgeniy Sergeevich Severin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of medicine, particularly in cancer treatment. His innovative work focuses on the development of a polypeptide that enhances the efficacy of anticancer agents.
Latest Patents
Evgeniy Severin holds 1 patent for his invention titled "Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon." This inventive polypeptide is designed as a fragment of the epidermal growth factor, consisting of amino acids ranging from 21 to 31. It is capable of efficiently binding with the receptor of the epidermal growth factor, serving as a vector for the targeted delivery of anticancer agents to tumor cells. The conjugate of this polypeptide contains doxorubicine, which exhibits selective action on cancer tumors and can significantly reduce the resistance of tumor cells to anticancer agents. The conjugated components are linked by a chemical bond that is unstable in relation to acid hydrolysis. The pharmaceutical composition includes an effective quantity of the conjugate and a carrier suitable for intravenous injection, making it a promising option for treating cancer patients.
Career Highlights
Evgeniy Severin is associated with Zakrytoe Aktsionernoe Obschestvo “Russkie Biotechnologll,” where he continues to advance his research and development efforts in biotechnology. His work is pivotal in the ongoing fight against cancer, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Evgeniy collaborates with notable colleagues, including Sergey Evgenyevich Severin and Sergey Viktorovich Lutsenko. Their combined expertise contributes to the advancement of biotechnological innovations.
Conclusion
Evgeniy Sergeevich Severin stands out as a dedicated inventor in the field of cancer treatment, with a focus on developing effective therapeutic solutions. His contributions are vital in the ongoing battle against cancer, and his innovative approaches hold promise for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile